Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs.
Protection against viral challenge with canine oral papillomavirus (COPV) was achieved by immunisation via particle-mediated DNA delivery (PMDD) of a plasmid encoding the COPV L1 gene to cutaneous and oral mucosal sites in beagle dogs. The initial dose of approximately 9 microg of DNA was followed by two booster doses at 6 week intervals. A similar approach was used to vaccinate a control group of animals with plasmid DNA encoding the Hepatitis B virus S gene. Following challenge at the oral mucosa with COPV all animals vaccinated with the COPV L1 gene were protected against disease. However five of six animals in the control group developed COPV induced papillomas at the oral mucosa. Both cell-mediated lymphoproliferative and humoral antibody responses to the DNA vaccine were observed. Our data indicate that PMDD of plasmid DNA can protect against mucosal challenge with papillomavirus.
Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK.
M A
MA
Stanley
R A
RA
Moore
P K
PK
Nicholls
E B
EB
Santos
L
L
Thomsen
N
N
Parry
S
S
Walcott
G
G
Gough
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D002213:Capsid / Q000235:genetics* / Q000276:immunology; D004285:Dogs; D008213:Lymphocyte Activation; D027383:Papillomaviridae / Q000235:genetics / Q000276:immunology*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D014412:Tumor Virus Infections / Q000517:prevention & control*; D014611:Vaccination; D019444:Vaccines, DNA / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*; D001616:beta-Galactosidase / Q000235:genetics
D000914:Antibodies, Viral; D019444:Vaccines, DNA; D014765:Viral Vaccines; D001616:beta-Galactosidase